Information  X 
Enter a valid email address

Company Name matching 'PharmaSGP Holding SE'

Date
Time Source
Company
Announcement
15 Sep 2021 5:58 pm EQS   PharmaSGP Holding SE PharmaSGP Holding SE raises forecast for FY 2021 following completion of acquisition of OTC brand portfolio
27 Aug 2021 2:08 pm EQS   PharmaSGP Holding SE Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution
12 Jul 2021 1:28 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
15 Jun 2021 5:02 pm EQS   PharmaSGP Holding SE PharmaSGP Group acquires OTC brand portfolio (Baldriparan, Formigran, Spalt  and Kamol) from GSK
11 May 2021 8:43 am EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
19 Apr 2021 8:58 am EQS   PharmaSGP Holding SE Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
16 Apr 2021 2:17 pm EQS   PharmaSGP Holding SE Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
11 Feb 2021 4:39 pm EQS   PharmaSGP Holding SE PharmaSGP Holding SE announces preliminary FY 2020 revenue and earnings trends after suspension of forecast
27 Nov 2020 4:38 pm EQS   PharmaSGP Holding SE Adjustment of full-year forecast 2020 due to expected weaker fourth quarter following COVID-19-related restrictions
08 Oct 2020 1:17 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
16 Sep 2020 12:52 pm EQS   PharmaSGP Holding SE Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
06 Jul 2020 3:50 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Jun 2020 3:28 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
25 Jun 2020 10:18 am EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  10:09 am EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  10:05 am EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
22 Jun 2020 3:30 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:27 pm EQS   PharmaSGP Holding SE Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
18 Jun 2020 10:05 pm EQS   PharmaSGP Holding SE Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  9:57 pm EQS   PharmaSGP Holding SE PharmaSGP Holding SE sets offer price at €31.50 per share


Company Announcements Archive »


a d v e r t i s e m e n t